The Asia-Pacific Extreme Lateral Interbody Fusion (XLIF) Surgery Market was valued at USD 1.17 Billion in 2025 and is expected to reach USD 1.93 Billion by 2033, growing at a CAGR of 6.5% (2026-2033).